On November 1, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) reported that the company will host its third quarter 2017 investor conference call and webcast at 8:30 am ET on Wednesday, November 8, 2017 (Press release, Merrimack, NOV 1, 2017, View Source [SID1234521390]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The call will cover an update on Merrimack’s recent progress as well as a summary of third quarter 2017 financial results. A press release detailing the information to be discussed on the call will be issued the morning of Wednesday, November 8, 2017. Investors and the general public are invited to listen to the call by dialing (877) 564-1301 (domestic) or (224) 357-2394 (international) five minutes prior to the start of the call and providing the passcode 6187659.

A listen-only webcast of the call will be available in the Investors section of Merrimack’s website, investors.merrimack.com, and a replay of the call will be archived there for six weeks.

On November 1, 2017 Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, reported it will release third quarter 2017 financial results after the market closes on Thursday, November 9th, 2017 (Press release, Intrexon, NOV 1, 2017, View Source [SID1234521389]). The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call may be accessed by dialing 1-888-317-6003 (Domestic US), 1-866-284-3684 (Canada), and 1-412-317-6061 (International) and providing the number 7741944 to join the Intrexon Corporation Call. Participants may also access the live webcast through Intrexon’s website in the Investors section at View Source